Results published recently in the Journal of Chemical Information and Modeling of the American Chemical Society describe the strides made by this collaborative research team working at the interface of biochemistry and computing.
Interactions between proteins are fundamental to biological processes. This presents an opportunity to use natural inhibitors or activators of these protein interactions as potential drug targets. However, their natural properties do not lend themselves to becoming candidate drugs and they often need to be modified to be effective.
Professor Shields uses the software package developed by Siemens to identify and screen vast numbers of compounds in order to compare structural motifs of peptides in proteins and small molecules, including potential drugs. The software developed has enabled analysis on a scale that would not be feasible on the laboratory bench.
By finding similar structures and potential compatibilities, it may be possible to block surface contacts of the proteins and control their interactions with other proteins. This potential may prove invaluable when it comes to designing novel drug therapies.
This work was supported by Scientific Foundation Ireland and Siemens as Industry Supplement Research Partnership programme between UCD and Siemens Research Ireland. The Irish Centre for High-End Computing (ICHEC) is acknowledged for their computational resources.
Elaine Quinn | Source: alphagalileo
Further information: www.ucd.ie/conway/news_243.html
More articles from
Information Technology:
Boosting the capabilities of emergency relief efforts
13.10.2008 | ICT Results
Innovative search for world’s biggest physics laboratory
08.10.2008 | Fraunhofer-Institut fuer Graphische Datenverarbeitung IGD
Brightening the future for optical circuits
13.10.2008 | Physics and Astronomy
Scientists discover bacteria that can cause bone infections
13.10.2008 | Life Sciences
Europe Rallies Behind Nanotechnology To Wean World From Fossil Fuels
13.10.2008 | Ecology, The Environment and Conservation